Exposure group:Treatment of Yifeiyin+EGFR-TKIS

2 trials

Sponsors

Tongde Hospital of Zhejiang Province

Conditions

non-small cell lung cancer

Unknown Phase

Clinical efficacy and immune mechanism of yifeiyin in delaying TKI resistance in non-small cell lung cancer

Active, not recruitingITMCTR2000003377

Tongde Hospital of Zhejiang Provincenon-small cell lung cancer

Start: 2021-01-01Updated: 2023-02-20

Clinical efficacy and immune mechanism of yifeiyin in delaying TKI resistance in non-small cell lung cancer

Active, not recruitingChiCTR2000033640

Tongde Hospital of Zhejiang Provincenon-small cell lung cancer

Start: 2021-01-01Updated: 2020-06-08